Fig. 2From: The sodium–glucose co-transporter 2 inhibitor empagliflozin attenuates cardiac fibrosis and improves ventricular hemodynamics in hypertensive heart failure ratsOccurrence of atrial and ventricular premature beats in hypertensive rats. Representative electrocardiographic tracings for normotensive rats (WKY, trace a), hypertensive rats (SHR, traces b, c) and empagliflozin-treated hypertensive rats (EMPA, traces d, e). Premature beats were specifically labeled as APC for an atrial origin, and VPC for a ventricular origin. The number of APC and VPC for each rat (f, g) was calculated from 5 min ECG recordingBack to article page